Adjustment for competing risk in kin-cohort estimation

被引:12
作者
Chatterjee, N [1 ]
Hartge, P [1 ]
Wacholder, S [1 ]
机构
[1] NCI, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA
关键词
BRCA1/2; mutations; cause-specific hazard; cohort study; multiple outcomes; penetrance; ESTIMATING PENETRANCE; BREAST-CANCER; MUTATION; DESIGNS; BRCA1;
D O I
10.1002/gepi.10269
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学];
摘要
Kin-cohort design can be used to study the effect of a genetic mutation on the risk of multiple events, using the same study. In this design, the outcome data consist of the event history of the relatives of a sample of genotyped subjects. Existing methods for kin-cohort estimation allow estimation of the risk of one event at a time with the assumption that the censoring events are unrelated to the genetic mutation under study. These methods, however, may produce biased estimates of risk when multiple events are related to the genetic mutation, and follow-up of some of the events may be censored by the onset of other events. Using a competing risk framework to address this problem, we show that cause-specific hazard functions for carriers and noncarriers are identifiable from kin-cohort data. For estimation, we propose an extension of a composite-likelihood approach we described previously. We illustrate the use of the proposed method for estimation of the risk of ovarian cancer from BRCA1/2 mutations in the absence of breast cancer, based on data from the Washington Ashkenazi Kin-Cohort Study. We also evaluate the performance of the proposed estimation method, based on simulated data that were generated following the setup of the Washington Ashkenazi Study. Published 2003 Wiley-Liss, Inc.
引用
收藏
页码:303 / 313
页数:11
相关论文
共 16 条
[1]
A marginal likelihood approach for estimating penetrance from kin-cohort designs [J].
Chatterjee, N ;
Wacholder, S .
BIOMETRICS, 2001, 57 (01) :245-252
[2]
EFORN B, 1993, INTRO BOOTSTRAP
[3]
Gail M H, 1999, J Natl Cancer Inst Monogr, P55
[4]
PROJECTING INDIVIDUALIZED PROBABILITIES OF DEVELOPING BREAST-CANCER FOR WHITE FEMALES WHO ARE BEING EXAMINED ANNUALLY [J].
GAIL, MH ;
BRINTON, LA ;
BYAR, DP ;
CORLE, DK ;
GREEN, SB ;
SCHAIRER, C ;
MULVIHILL, JJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (24) :1879-1886
[5]
Gail MH, 1999, GENET EPIDEMIOL, V16, P15, DOI 10.1002/(SICI)1098-2272(1999)16:1<15::AID-GEPI3>3.0.CO
[6]
2-8
[7]
Godambe V.P., 1991, Estimating Functions
[8]
Kalbfleisch JD., 1980, STAT ANAL FAILURE TI
[9]
Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers [J].
Lee, JS ;
Wacholder, S ;
Struewing, JP ;
McAdams, M ;
Pee, D ;
Brody, LC ;
Tucker, MA ;
Hartge, P .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (03) :259-263
[10]
LIANG KY, 1992, J R STAT SOC B, V54, P3